My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 21

    1.

    Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial.

    Brundage M, Gropp M, Mefti F, Mann K, Lund B, Gebski V, Wolfram G, Reed N, Pignata S, Ferrero A, Brown C, Eisenhauer E, Pujade-Lauraine E.

    Ann Oncol. 2012 Jan 30. [Epub ahead of print]

    PMID:
    22291207
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study.

    Gao Y, Liu Z, Chen X, Luo W, Zhang L, Wang J.

    BMC Cancer. 2011 Oct 11;11:439.

    PMID:
    21989202
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    3.

    The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.

    Sernbo S, Gustavsson E, Brennan DJ, Gallagher WM, Rexhepaj E, Rydnert F, Jirström K, Borrebaeck CA, Ek S.

    BMC Cancer. 2011 Sep 24;11:405.

    PMID:
    21943380
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    4.

    Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: a tangible union against chemoresistant cancer.

    Singh PP, Joshi S, Russell PJ, Nair S, Khatri A.

    BMC Cancer. 2011 Aug 24;11:368.

    PMID:
    21861932
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    5.

    15. Cancers attributable to reproductive factors in the UK in 2010.

    Parkin DM.

    Br J Cancer. 2011 Dec 6;105 Suppl 2:S73-6. doi: 10.1038/bjc.2011.488. No abstract available.

    PMID:
    22158326
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    6.

    10. Cancers attributable to exposure to hormones in the UK in 2010.

    Parkin DM.

    Br J Cancer. 2011 Dec 6;105 Suppl 2:S42-8. doi: 10.1038/bjc.2011.483. No abstract available.

    PMID:
    22158320
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    7.

    Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells.

    Yang X, Wang J, Zhou Y, Wang Y, Wang S, Zhang W.

    Cancer Lett. 2012 Aug 28;321(2):137-43. Epub 2012 Jan 25.

    PMID:
    22281241
    [PubMed - in process]

    Related citations

    8.

    Ovarian cancer risk associated with inherited inflammation-related variants.

    White KL, Schildkraut JM, Palmieri RT, Iversen ES Jr, Berchuck A, Vierkant RA, Rider DN, Charbonneau B, Cicek MS, Sutphen R, Birrer MJ, Pharoah PP, Song H, Tyrer J, Gayther SA, Ramus SJ, Wentzensen N, Yang HP, Garcia-Closas M, Phelan CM, Cunningham JM, Fridley BL, Sellers TA, Goode EL; Ovarian Cancer Association Consortium.

    Cancer Res. 2012 Mar 1;72(5):1064-9. Epub 2012 Jan 26.

    PMID:
    22282663
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer.

    Song T, Choi CH, Cho YJ, Sung CO, Song SY, Kim TJ, Bae DS, Lee JW, Kim BG.

    Gynecol Oncol. 2012 May;125(2):427-32. Epub 2012 Jan 28.

    PMID:
    22285843
    [PubMed - in process]

    Related citations

    10.

    The more things change the more they stay the same.

    Mutch DG.

    Gynecol Oncol. 2012 Jan;124(1):3-4. Epub 2011 Oct 29. No abstract available.

    PMID:
    22040836
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.

    Guntupalli SR, Zighelboim I, Kizer NT, Zhang Q, Powell MA, Thaker PH, Goodfellow PJ, Mutch DG.

    Gynecol Oncol. 2012 Jan;124(1):31-5. Epub 2011 Oct 26.

    PMID:
    22030404
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Autoimmune mediated regulation of ovarian tumor growth.

    Altuntas CZ, Jaini R, Kesaraju P, Jane-wit D, Johnson JM, Covey K, Flask CA, Dutertre M, Picard JY, Tuohy VK.

    Gynecol Oncol. 2012 Jan;124(1):98-104. Epub 2011 Oct 18.

    PMID:
    22004903
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.

    Romero IL, Lee W, Mitra AK, Gordon IO, Zhao Y, Leonhardt P, Penicka CV, Mui KL, Krausz TN, Greene GL, Lengyel E.

    Gynecol Oncol. 2012 Jan;124(1):134-41. Epub 2011 Oct 11.

    PMID:
    21996264
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.

    Brunner A, Hinterholzer S, Riss P, Heinze G, Brustmann H.

    Gynecol Oncol. 2012 Jan;124(1):105-11. Epub 2011 Oct 6.

    PMID:
    21982044
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).

    Chi DS, Musa F, Dao F, Zivanovic O, Sonoda Y, Leitao MM, Levine DA, Gardner GJ, Abu-Rustum NR, Barakat RR.

    Gynecol Oncol. 2012 Jan;124(1):10-4. Epub 2011 Sep 13.

    PMID:
    21917306
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.

    Voss MA, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, Wei W, Sundar S.

    Gynecol Oncol. 2012 Jan;124(1):15-20. Epub 2011 Aug 23.

    PMID:
    21864888
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.

    Horiuchi A, Hayashi T, Kikuchi N, Hayashi A, Fuseya C, Shiozawa T, Konishi I.

    Int J Cancer. 2012 Jan 27. doi: 10.1002/ijc.27448. [Epub ahead of print]

    PMID:
    22287060
    [PubMed - as supplied by publisher]

    Related citations

    18.

    Stressed tumor cell, chemosensitized cancer.

    Wiemer EA.

    Nat Med. 2011 Dec 6;17(12):1552-4. doi: 10.1038/nm.2593. No abstract available.

    PMID:
    22146456
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.

    Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P, Sastre-Garau X, Mechta-Grigoriou F.

    Nat Med. 2011 Nov 20;17(12):1627-35. doi: 10.1038/nm.2512.

    PMID:
    22101765
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Effect of inhibition of the adrenomedullin gene on the growth and chemosensitivity of ovarian cancer cells.

    Chen P, Pang X, Zhang Y, He Y.

    Oncol Rep. 2012 May;27(5):1461-6. doi: 10.3892/or.2012.1655. Epub 2012 Jan 26.

    PMID:
    22294191
    [PubMed - in process]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk